首页 | 本学科首页   官方微博 | 高级检索  
检索        

精神分裂症与代谢综合征相关进展
引用本文:张京华,甄仲.精神分裂症与代谢综合征相关进展[J].医学综述,2012(21):3650-3652.
作者姓名:张京华  甄仲
作者单位:天津市安定医院1科C20区;中国中医科学院广安门医院内分泌科
基金项目:国家自然科学基金(81173451/H2902)
摘    要:精神分裂症患者合并代谢异常的比例明显高于普通人群,且精神分裂症本身可能是代谢综合征的危险因素。另外,抗精神病药物可引起体质量增加,血糖、血脂异常及胰岛素抵抗,这些因素均增加了精神疾病患者的代谢异常风险,因此精神科医师在关注专科治疗的同时,应重视代谢综合征的高危因素,并早期采取综合干预措施。

关 键 词:代谢综合征  精神分裂症  抗精神病药物  临床进展

Research Progress in Pathogenesis of Metabolic Syndrome and Schizophrenia
ZHANG Jing-hua,ZHEN Zhong.Research Progress in Pathogenesis of Metabolic Syndrome and Schizophrenia[J].Medical Recapitulate,2012(21):3650-3652.
Authors:ZHANG Jing-hua  ZHEN Zhong
Institution:1.Department 1 Zone C20,Tianjin Anding Hospital,Tianjin 300222,China;2.Department of Endocrinology,Guang′anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China)
Abstract:The prevalence of metabolic syndrome in patients with schizophrenia is much higher than that in general population.Schizophrenia might be a risk factor of metabolic syndrome.Antipsychotic drugs could cause weight gain,dysglycemia,lipid abnormality and insulin resistance,which all may increase the risk of metabolic dysregulation among schizophrenia patients.Psychiatrists should monitor metabolic problems and make early comprehensive interventions to limit the metabolic dysregulation in patients with schizophrenia.
Keywords:Metabolic syndromes  Schizophrenia  Antipsychotic drugs  Clinical progress
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号